Clinical Trials - Phase II

Found 27,993 articles

• Alfacell Provides Update On ONCONASE Clinical Program

  1/19/2006

• Antisense Therapeutics Limited Receives Approval To Restart Phase IIa Trial Of ATL1102 For Patients With Multiple Sclerosis

  1/18/2006

• Covalent Group, Inc. Signs Contract For $2.3 Million To Conduct A Multinational Phase 2 Clinical Trial Involving A New Antithrombotic Agent

  1/18/2006

• MannKind Corporation Announces Positive Results From A Phase 2b Dose-Ranging Study Of Technosphere(R) Insulin In Patients With Type 2

  1/17/2006

• ADVENTRX Pharmaceuticals Inc. To Present CoFactor Phase II Data At American Society of Clinical Oncology Gastrointestinal Cancer Conference

  1/17/2006

• Xanthus Life Sciences Initiates Phase 2 Clinical Trial With Symadex In Patients With Metastatic Colorectal Cancer

  1/17/2006

• AVAX Technologies, Inc. Announces Initiation Of Its Clinical Study For The Treatment Of Patients With Non Small Cell Lung Cancer

  1/17/2006

• CepTor Corporation Submits Investigational New Drug Application (IND) To Initiate Clinical Trials With Myodur (C-101) In Duchenne Muscular Dystrophy (DMD) Patients

  1/17/2006

• Five Abstracts Related To VaxGen, Inc.'s Smallpox Vaccine To Be Presented At ASM Biodefense Research Meeting

  1/17/2006

• Genentech, Inc. Halts Trial Of Allergy Drug

  1/17/2006

• Thoratec Corporation Says More Than 200 Total Patients Have Been Enrolled In Worldwide HeartMate(R) II Trial Experience

  1/12/2006

• Sangamo BioSciences, Inc. Announces Plans For Phase 2 Clinical Trial Of ZFP Therapeutic In Diabetic Neuropathy At JPMorgan Healthcare Conference

  1/12/2006

• Novagali Pharma Successfully Completes Phase II Clinical Study With Its Ophthalmic Formulation Of Cyclosporine A

  1/11/2006

• Valentis, Inc. Announces Favorable Interim Phase IIb Analysis, Efficacy Results On Course For Mid-Year

  1/11/2006

• European Commission Grants Orphan Drug Status For AmpliMed Corporation's Amplimexon(R) For The Treatment Of Ovarian Cancer

  1/11/2006

• Adherex Technologies Inc. Announces Corporate Goals For 2006

  1/11/2006

• BiovaxID(TM), Personalized Anti-Cancer Vaccine From Biovest International, Inc., Produces Long Term Clinical Remission And 95 Percent Overall Survival In Patients With Follicular Non-Hodgkin's Lymphoma In Phase 2 Clinical Trial

  1/10/2006

• Nymox Pharmaceutical Provides Update On Progress Of The Company's Current Drug Trial Of NX-1207 For Benign Prostatic Hyperplasia

  1/10/2006

• Bristol-Myers Squibb Company And Gilead Sciences (Foster City, CA) Advance Combo AIDS Treatment

  1/9/2006

• Biogen Idec, Inc. (BIIB) Phase II Study Of Oral Compound BG-12 Meets Primary Endpoint In Multiple Sclerosis

  1/9/2006